0001437749-20-013987.txt : 20200626 0001437749-20-013987.hdr.sgml : 20200626 20200626160511 ACCESSION NUMBER: 0001437749-20-013987 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200624 FILED AS OF DATE: 20200626 DATE AS OF CHANGE: 20200626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BALTHROP PATRICK J CENTRAL INDEX KEY: 0001284839 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 20994140 MAIL ADDRESS: STREET 1: 243 LEEDS COURT CITY: LAKE BLUFF STATE: IL ZIP: 60044 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2020-06-24 0001586049 Oxford Immunotec Global PLC OXFD 0001284839 BALTHROP PATRICK J C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 Ordinary Shares 2020-06-24 4 A 0 4081 0 A 4081 D Share Option (Right to Buy) 12.96 2020-06-24 4 A 0 9494 0 A 2030-06-24 Ordinary Shares 9494 9494 D Options granted under Issuer's 2013 Share Incentive Plan. This option will vest and become exercisable as to 100% of the underlying shares on the earlier of the first anniversary of the date of grant or the date of the first annual general meeting of the shareholders held after the date of grant. /s/ Matthew T E McLaughlin, as Attorney-in-Fact for Patrick J. Balthrop, Sr. 2020-06-26